论文部分内容阅读
病例简介患者25岁,已婚3年未孕。月经稀发3～6个月一次,每次5～7天,量中等。输卵管通水及输卵管造影均示通畅。丈夫精液分析正常。既往BBT 单相型,经前子宫内膜活检为“增生期内膜”,经多次使用克罗米芬诱发排卵失败。体重65kg,腹中线及小腿皮肤毛多且长。外阴、阴道及宫颈正常,宫体前倾,大小质地正常,双侧卵巢稍大,双侧乳房挤压无乳汁。LH50IU/L,FSH15IU/L,PRL15μg/L,孕酮试验阳性。患者末次月经始于1988年11月16日,于11月20日开始服克罗米芬,每日100mg,连续5天。于11月23日始肌注hMG2支/日(1支hMG 含FSH 及LH 各75IU),连续3天。从11月26日(周期第11天)起每天作B 型超声检查及血清E_2放射免疫测定,监测卵泡发育,结果见附表。
Case description Patient 25 years old, married 3 years not pregnant. Menstrual thinning 3 to 6 months once, each 5 to 7 days, the amount of medium. Tubal water and salpingography showed smooth. Her husband’s semen analysis was normal. Previous BBT single-phase type, pre-menstrual endometrial biopsy as “proliferative endometrium”, after repeated use of clomiphene-induced ovulation failure. Weight 65kg, belly line and calf skin hair and more long. Vulva, vagina and cervix normal, Palace lean forward, the size of the normal texture, slightly larger bilateral ovaries, bilateral breast compression without milk. LH50IU / L, FSH15IU / L, PRL15μg / L, progesterone test positive. The patient’s last menstrual period began on November 16, 1988, beginning on November 20 with clomiphene citrate, 100 mg daily for five consecutive days. On November 23, intramuscular injection of hMG2 support / day (1 hMG with FSH and LH of 75IU) for 3 consecutive days. From November 26 (the first 11 days) from day to day for type B ultrasound examination and serum E 2 radioimmunoassay to monitor follicular development, the results see Schedule.